• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲磺酸依普罗沙坦自微乳给药系统的制剂及统计学优化,以提高口服生物利用度。

Formulation and statistical optimization of self-microemulsifying drug delivery system of eprosartan mesylate for improvement of oral bioavailability.

机构信息

Department of Pharmaceutics, Kamla Nehru College of Pharmacy, Butibori, Nagpur, Maharashtra, 441108, India.

Department of Pharmaceutics, Suresh GyanVihar University, Mahal, Jagtpura, Jaipur, Rajasthan, 302025, India.

出版信息

Drug Deliv Transl Res. 2016 Oct;6(5):610-21. doi: 10.1007/s13346-016-0318-7.

DOI:10.1007/s13346-016-0318-7
PMID:27465619
Abstract

The present investigation is aimed to design a statistically optimized self-microemulsifying drug delivery system (SMEDDS) of eprosartan mesylate (EM). Preliminary screening was carried out to find a suitable combination of various excipients for the formulation. A 3(2) full factorial design was employed to determine the effect of various independent variables on dependent (response) variables. The independent variables studied in the present work were concentration of oil (X 1) and the ratio of S mix (X 2), whereas the dependent variables were emulsification time (s), globule size (nm), polydispersity index (pdi), and zeta potential (mV), and the multiple linear regression analysis (MLRA) was employed to understand the influence of independent variables on dependent variables. Furthermore, a numerical optimization technique using the desirability function was used to develop a new optimized formulation with desired values of dependent variables. The optimized SMEDDS formulation of eprosartan mesylate (EMF-O) by the above method exhibited emulsification time, 118.45 ± 1.64 s; globule size, 196.81 ± 1.29 nm; zeta potential, -9.34 ± 1.2 mV, and polydispersity index, 0.354 ± 0.02. For the in vitro dissolution study, the optimized formulation (EMF-O) and pure drug were separately entrapped in the dialysis bag, and the study indicated higher release of the drug from EMF-O. In vivo pharmacokinetic studies in Wistar rats using PK solver software revealed 2.1-fold increment in oral bioavailability of EM from EMF-O, when compared with plain suspension of pure drug.

摘要

本研究旨在设计一种统计学优化的甲磺酸依普罗沙坦自微乳给药系统(SMEDDS)。进行初步筛选以找到适合制剂的各种赋形剂的组合。采用 3(2)完全析因设计来确定各种独立变量对依赖(响应)变量的影响。本工作中研究的独立变量是油的浓度(X1)和 S 混合物的比例(X2),而依赖变量是乳化时间(s)、粒径(nm)、多分散指数(pdi)和zeta 电位(mV),并采用多元线性回归分析(MLRA)来了解独立变量对依赖变量的影响。此外,还使用了具有理想性函数的数值优化技术,以开发具有所需依赖变量值的新优化配方。通过上述方法得到的甲磺酸依普罗沙坦优化 SMEDDS 配方(EMF-O)表现出乳化时间为 118.45±1.64s;粒径为 196.81±1.29nm;zeta 电位为-9.34±1.2mV,多分散指数为 0.354±0.02。对于体外溶出研究,将优化配方(EMF-O)和纯药物分别包封在透析袋中,研究表明从 EMF-O 中释放出更多的药物。使用 PK Solver 软件进行的 Wistar 大鼠体内药代动力学研究表明,与纯药物的普通混悬液相比,从 EMF-O 中口服生物利用度提高了 2.1 倍。

相似文献

1
Formulation and statistical optimization of self-microemulsifying drug delivery system of eprosartan mesylate for improvement of oral bioavailability.甲磺酸依普罗沙坦自微乳给药系统的制剂及统计学优化,以提高口服生物利用度。
Drug Deliv Transl Res. 2016 Oct;6(5):610-21. doi: 10.1007/s13346-016-0318-7.
2
Self-microemulsifying Drug Delivery System for Solubility and Bioavailability Enhancement of Eprosartan Mesylate: Preparation, , and Evaluation.马来酸依普罗沙坦自微乳药物传递系统的增溶和生物利用度研究:制备、评价和考察。
Pharm Nanotechnol. 2023;11(1):56-69. doi: 10.2174/2211738510666220915100150.
3
Risk assessment and QbD based optimization of an Eprosartan mesylate nanosuspension: In-vitro characterization, PAMPA and in-vivo assessment.基于风险评估和 QbD 的甲磺酸依普罗沙坦纳米混悬剂的优化:体外特性研究、PAMPA 和体内评价。
Int J Pharm. 2019 Aug 15;567:118415. doi: 10.1016/j.ijpharm.2019.06.006. Epub 2019 Jun 5.
4
Solid self-microemulsifying drug delivery system of ritonavir.利托那韦固体自微乳药物传递系统。
Drug Dev Ind Pharm. 2014 Apr;40(4):477-87. doi: 10.3109/03639045.2013.768632. Epub 2013 Mar 7.
5
Quality-by-design based development of a self-microemulsifying drug delivery system to reduce the effect of food on Nelfinavir mesylate.基于质量源于设计理念开发自微乳化药物递送系统以降低食物对甲磺酸奈非那韦的影响。
Int J Pharm. 2016 Mar 30;501(1-2):311-25. doi: 10.1016/j.ijpharm.2016.02.008. Epub 2016 Feb 6.
6
Optimization of self-microemulsifying drug delivery system for telmisartan using Box-Behnken design and desirability function.采用 Box-Behnken 设计和可满意度函数优化替米沙坦自微乳给药系统。
J Pharm Pharmacol. 2013 Oct;65(10):1440-50. doi: 10.1111/jphp.12115. Epub 2013 Jul 24.
7
Novel bicephalous heterolipid based self-microemulsifying drug delivery system for solubility and bioavailability enhancement of efavirenz.新型双头异质脂基自微乳给药系统提高依非韦伦的溶解度和生物利用度。
Int J Pharm. 2019 Apr 5;560:205-218. doi: 10.1016/j.ijpharm.2019.01.065. Epub 2019 Feb 10.
8
Development of phyllanthin-loaded self-microemulsifying drug delivery system for oral bioavailability enhancement.用于提高口服生物利用度的叶下珠素自微乳化药物递送系统的研发。
Drug Dev Ind Pharm. 2015 Feb;41(2):207-17. doi: 10.3109/03639045.2013.858732. Epub 2013 Nov 18.
9
Eprosartan mesylate loaded bilosomes as potential nano-carriers against diabetic nephropathy in streptozotocin-induced diabetic rats.甲磺酸依普罗沙坦载入双分子层囊泡作为潜在的纳米载体,用于治疗链脲佐菌素诱导的糖尿病大鼠的糖尿病肾病。
Eur J Pharm Sci. 2018 Jan 1;111:409-417. doi: 10.1016/j.ejps.2017.10.012. Epub 2017 Oct 10.
10
Preparation and In Vitro/In Vivo Evaluation of Puerarin Solid Self-Microemulsifying Drug Delivery System by Spherical Crystallization Technique.采用球形结晶技术制备葛根素固体自微乳化药物传递系统及其体外/体内评价
AAPS PharmSciTech. 2016 Dec;17(6):1336-1346. doi: 10.1208/s12249-015-0469-8. Epub 2015 Dec 22.

引用本文的文献

1
Formulation development, in vivo bioequivalence and pediatric PBPK modeling studies of taste-masked ciprofloxacin chewable tablets.掩味环丙沙星咀嚼片的制剂开发、体内生物等效性和儿科 PBPK 模型研究。
Sci Rep. 2023 Sep 26;13(1):16070. doi: 10.1038/s41598-023-43423-0.
2
Solid Self-Nano Emulsifying Nanoplatform Loaded with Tamoxifen and Resveratrol for Treatment of Breast Cancer.负载他莫昔芬和白藜芦醇的固体自纳米乳化纳米平台用于乳腺癌治疗
Pharmaceutics. 2022 Jul 18;14(7):1486. doi: 10.3390/pharmaceutics14071486.
3
Development of ritonavir-loaded nanostructured lipid carriers employing quality by design (QbD) as a tool: characterizations, permeability, and bioavailability studies.

本文引用的文献

1
Preparation and Characterization of Self-Microemulsifying Drug Delivery System of Olmesartan Medoxomil for Bioavailability Improvement.用于提高生物利用度的奥美沙坦酯自微乳化药物递送系统的制备与表征
J Pharm (Cairo). 2013;2013:728425. doi: 10.1155/2013/728425. Epub 2012 Sep 24.
2
Development of isradipine loaded self-nano emulsifying powders for improved oral delivery: in vitro and in vivo evaluation.用于改善口服给药的伊拉地平自纳米乳化粉末的研制:体外和体内评价
Drug Dev Ind Pharm. 2015 May;41(5):753-63. doi: 10.3109/03639045.2014.900081. Epub 2014 Mar 18.
3
Self-emulsifying drug delivery system and the applications in herbal drugs.
采用质量源于设计(QbD)工具制备利托那韦载药纳米结构脂质载体:特性、渗透性和生物利用度研究。
Drug Deliv Transl Res. 2022 Jul;12(7):1753-1773. doi: 10.1007/s13346-021-01083-5. Epub 2021 Oct 20.
4
Integration of phospholipid-drug complex into self-nanoemulsifying drug delivery system to facilitate oral delivery of paclitaxel.将磷脂 - 药物复合物整合到自纳米乳化药物递送系统中以促进紫杉醇的口服给药。
Asian J Pharm Sci. 2019 Sep;14(5):552-558. doi: 10.1016/j.ajps.2018.10.003. Epub 2018 Nov 20.
5
Quality by Design Approach Using Multiple Linear and Logistic Regression Modeling Enables Microemulsion Scale Up.采用多元线性和逻辑回归建模的质量源于设计方法可实现微乳的放大。
Molecules. 2019 May 30;24(11):2066. doi: 10.3390/molecules24112066.
6
Self-nanoemulsifying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis.布鲁士碱 D 的自微乳药物传递系统:一种治疗溃疡性结肠炎的新方法。
Int J Nanomedicine. 2018 Sep 28;13:5887-5907. doi: 10.2147/IJN.S174146. eCollection 2018.
7
Characterization of brusatol self-microemulsifying drug delivery system and its therapeutic effect against dextran sodium sulfate-induced ulcerative colitis in mice.毛果算盘子素自微乳化给药系统的表征及其对葡聚糖硫酸钠诱导的小鼠溃疡性结肠炎的治疗作用
Drug Deliv. 2017 Nov;24(1):1667-1679. doi: 10.1080/10717544.2017.1384521.
8
Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation.依达拉奉脂质纳米系统:研发、优化、表征及体外/体内评价
Drug Deliv. 2017 Nov;24(1):962-978. doi: 10.1080/10717544.2017.1337825.
自乳化药物递送系统及其在草药中的应用。
Drug Deliv. 2015;22(4):475-86. doi: 10.3109/10717544.2013.861659. Epub 2013 Dec 9.
4
Self micro-emulsifying drug delivery system of tacrolimus: Formulation, in vitro evaluation and stability studies.他克莫司自微乳化药物递送系统:处方、体外评价及稳定性研究。
Int J Pharm Investig. 2013 Apr;3(2):95-104. doi: 10.4103/2230-973X.114899.
5
Self nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation.瑞舒伐他汀钙自微乳给药系统(SNEDDS)的设计、制剂、生物利用度和药代动力学评价。
Colloids Surf B Biointerfaces. 2013 Dec 1;112:337-43. doi: 10.1016/j.colsurfb.2013.08.025. Epub 2013 Aug 28.
6
Nano scale self-emulsifying oil based carrier system for improved oral bioavailability of camptothecin derivative by P-Glycoprotein modulation.纳米级自乳化油载体制剂系统通过调节 P-糖蛋白改善喜树碱衍生物的口服生物利用度。
Colloids Surf B Biointerfaces. 2013 Nov 1;111:346-53. doi: 10.1016/j.colsurfb.2013.06.001. Epub 2013 Jun 15.
7
Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides.优化的依泽替米贝自微乳给药系统,使用长链和中链甘油三酯提高生物利用度。
Colloids Surf B Biointerfaces. 2012 Dec 1;100:50-61. doi: 10.1016/j.colsurfb.2012.05.019. Epub 2012 May 24.
8
Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).辅料在自乳化/微乳药物传递系统(SEDDS/SMEDDS)成功开发中的作用。
Drug Dev Ind Pharm. 2013 Jan;39(1):1-19. doi: 10.3109/03639045.2012.660949. Epub 2012 Feb 29.
9
Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability.自乳化药物传递系统:提高口服生物利用度的一种方法。
Drug Discov Today. 2010 Nov;15(21-22):958-65. doi: 10.1016/j.drudis.2010.08.007. Epub 2010 Aug 17.
10
Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.载利伐斯的明 PLGA 和 PBCA 纳米粒的制备、优化、表征、体外及药效学研究。
Eur J Pharm Biopharm. 2010 Oct;76(2):189-99. doi: 10.1016/j.ejpb.2010.07.007. Epub 2010 Jul 15.